Obinutuzumab
232516
Phase 2 mab active
Quick answer
Obinutuzumab for Mantle Cell Lymphoma is a Phase 2 program (mab) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Adaptive Biotechnologies Corp
- Indication
- Mantle Cell Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active